4-143185514-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001290326.1(USP38):​c.-1418G>T variant causes a 5 prime UTR premature start codon gain change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

USP38
NM_001290326.1 5_prime_UTR_premature_start_codon_gain

Scores

1
6
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.63
Variant links:
Genes affected
USP38 (HGNC:20067): (ubiquitin specific peptidase 38) Enables thiol-dependent deubiquitinase. Involved in protein deubiquitination. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21759272).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USP38NM_032557.6 linkc.64G>T p.Val22Leu missense_variant Exon 1 of 10 ENST00000307017.9 NP_115946.2 Q8NB14-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USP38ENST00000307017.9 linkc.64G>T p.Val22Leu missense_variant Exon 1 of 10 1 NM_032557.6 ENSP00000303434.4 Q8NB14-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 08, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.64G>T (p.V22L) alteration is located in exon 1 (coding exon 1) of the USP38 gene. This alteration results from a G to T substitution at nucleotide position 64, causing the valine (V) at amino acid position 22 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.72
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.058
.;T
Eigen
Benign
0.037
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.22
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M;M
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.97
N;N
REVEL
Benign
0.055
Sift
Uncertain
0.027
D;D
Sift4G
Benign
0.064
T;D
Polyphen
0.025
.;B
Vest4
0.42
MutPred
0.28
Loss of methylation at K24 (P = 0.1034);Loss of methylation at K24 (P = 0.1034);
MVP
0.23
MPC
0.84
ClinPred
0.96
D
GERP RS
4.4
Varity_R
0.59
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr4-144106667; API